An Updated Meta-analysis on the Risk of Urologic Cancer in Patients with Systemic Lupus Erythematosus

Jina Yeo ¹ , Min-Seok Seo ^2,3 , In Cheol Hwang ⁴ * , Jae-Yong Shim ³

Cited by CrossRef: 2

1- Ou J, Zhen K, Wu Y, Xue Z, Fang Y, Zhang Q, Bi H, Tian X, Ma L, Liu C. Systemic lupus erythematosus and prostate cancer risk: a pool of cohort studies and Mendelian randomization analysis. J Cancer Res Clin Oncol. 2023;149(12):9517 [Crossref]

2- Jubber I, Ong S, Bukavina L, Black P, Compérat E, Kamat A, Kiemeney L, Lawrentschuk N, Lerner S, Meeks J, Moch H, Necchi A, Panebianco V, Sridhar S, Znaor A, Catto J, Cumberbatch M. Epidemiology of Bladder Cancer in 2023: A Systematic Review of Risk Factors. European Urology. 2023;84(2):176 [Crossref]

Submit Your Paper Notification Instructions for Authors Aims and Scope Editorial policies Editorial Board AIM old site Archive

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.